poisar

Stock

SciSparc Ltd. SPRC

$9.09+70.54%

Overview

SPRC market data

Price History

SPRC price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$299.98
Diluted earnings per share over the trailing twelve months.
Beta
2.47
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$2.98 – $80.10
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $3.1 · P/B 1.05 · P/S 2.32.

Company News

10 captured
SciSparc shares are trading higher. The company announced its NeuroThera has completed internal validation of a proprietary quantum sampling workflow developed platform for clinical trials data analysis.Benzinga · Jul 29, 2026, 2:04 PM
SciSparc's NeuroThera Labs Subsidiary Completes Internal Validation Of Quantum Sampling Workflow Developed Platform For Clinical Trials Data AnalysisBenzinga · Jul 29, 2026, 12:35 PM
SciSparc Announces Decision To Target Agentic AI Market, To Establish Scientific Advisory Board To Focus On AI And CybersecurityBenzinga · Jul 27, 2026, 12:27 PM
SciSparc’s subsidiary NeuroThera Labs Initiates Phase IIb Clinical Trial Site At Hannover Medical School In Germany For SCI-110, Proprietary Cannabinoid-Based Treatment Candidate For Tourette Syndrome In AdultsBenzinga · Jul 15, 2026, 1:00 PM
SciSparc Subsidiary NeuroThera Labs Completes Acquisition Of ~54% Stake In CliniQuantumBenzinga · Jun 4, 2026, 11:40 AM
SciSparc Shares Halted On Circuit Breaker To The Upside, Stock Now Up 189.07%Benzinga · May 28, 2026, 6:51 PM
SciSparc Shares Halted On Circuit Breaker To The Upside, Stock Now Up 168.56%Benzinga · May 28, 2026, 6:42 PM
Why Is SciSparc Stock Skyrocketing On Thursday?Benzinga · May 28, 2026, 5:15 PM
Dow Jumps Around 200 Points; Best Buy Posts Upbeat Q1 ResultsBenzinga · May 28, 2026, 4:30 PM
SciSparc Shares Halted On Circuit Breaker To The Upside, Stock Now Up 183.14%Benzinga · May 28, 2026, 3:51 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
SciSparc Ltd. (SPRC) stock — price, valuation & news | Poisar